Visiomed Group SA
PAR:ALVMG

Watchlist Manager
Visiomed Group SA Logo
Visiomed Group SA
PAR:ALVMG
Watchlist
Price: 0.1726 EUR -1.82% Market Closed
Market Cap: 53.1m EUR
Have any thoughts about
Visiomed Group SA?
Write Note

Visiomed Group SA
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Visiomed Group SA
Cost of Revenue Peer Comparison

Comparables:
EDAP
BIM
ALCAR
ALBIO
AMPLI

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Visiomed Group SA
PAR:ALVMG
Cost of Revenue
-€789k
CAGR 3-Years
64%
CAGR 5-Years
30%
CAGR 10-Years
17%
Edap Tms SA
NASDAQ:EDAP
Cost of Revenue
-€36m
CAGR 3-Years
-16%
CAGR 5-Years
-10%
CAGR 10-Years
-9%
Biomerieux SA
PAR:BIM
Cost of Revenue
-€1.7B
CAGR 3-Years
-7%
CAGR 5-Years
-8%
CAGR 10-Years
-8%
Carmat SA
PAR:ALCAR
Cost of Revenue
-€35.1m
CAGR 3-Years
-4%
CAGR 5-Years
-1%
CAGR 10-Years
-8%
Biosynex SA
PAR:ALBIO
Cost of Revenue
-€43.8m
CAGR 3-Years
20%
CAGR 5-Years
-24%
CAGR 10-Years
-60%
Amplitude Surgical SA
PAR:AMPLI
Cost of Revenue
-€37.9m
CAGR 3-Years
5%
CAGR 5-Years
5%
CAGR 10-Years
N/A

See Also

What is Visiomed Group SA's Cost of Revenue?
Cost of Revenue
-789k EUR

Based on the financial report for Dec 31, 2023, Visiomed Group SA's Cost of Revenue amounts to -789k EUR.

What is Visiomed Group SA's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
17%

Over the last year, the Cost of Revenue growth was 77%. The average annual Cost of Revenue growth rates for Visiomed Group SA have been 64% over the past three years , 30% over the past five years , and 17% over the past ten years .

Back to Top